Effectiveness, safety/tolerability of OBV/PTV/r ± DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb/V and dialysis in Spanish clinical practice – preliminary data Vie-KinD study

View/ Open
Use this link to cite
http://hdl.handle.net/2183/21635
Except where otherwise noted, this item's license is described as Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC-BY-NC-ND 4.0)
Collections
- Investigación (FCS) [1289]
Metadata
Show full item recordTitle
Effectiveness, safety/tolerability of OBV/PTV/r ± DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb/V and dialysis in Spanish clinical practice – preliminary data Vie-KinD studyAuthor(s)
Date
2017Citation
Londoño MC, García-Buey L, Mallolas J, Barril G, Ahumada A, Riveiro-Barciela M,et al. Effectiveness, safety/tolerability of OBV/PTV/r ± DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb/V and dialysis in Spanish clinical practice – preliminary data Vie-KinD study [abstract]. J Hepatol. 2017;66(Suppl 1):S718-S719. Abstract nº SAT-226.
Description
Poster presentation
Editor version
Rights
Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC-BY-NC-ND 4.0)
ISSN
0168-8278